PLEXUS CORP
For the period ended Jun 29, 2024. Filed Aug 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 29, 2024 · Filed Aug 2, 2024
PLXS$205.18-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended | ||
|---|---|---|
| June 29,2024 | July 1,2023 | |
| Cash flows from operating activities | ||
| Net income | $70,594 | $98,833 |
| Adjustments to reconcile net income to net cash flows from operating activities: | ||
| Depreciation and amortization | 58,249 | 51,366 |
| Share-based compensation expense and related charges | 19,759 | 15,539 |
| Asset impairment charges | 4,736 | — |
| Deferred income tax expense (benefit) | 7,450 | (881) |
| Other, net | 2,230 | 955 |
| Changes in operating assets and liabilities, excluding impacts of currency: | ||
| Accounts receivable | 19,020 | 38,933 |
| Contract assets | 26,049 | 6,218 |
| Inventories | 131,519 | (25,356) |
| Other current and non-current assets | (30,984) | (2,408) |
| Accrued income taxes payable | (16,054) | (11,711) |
| Accounts payable | (39,217) | (115,600) |
| Advanced payments from customers | (25,297) | 14,145 |
| Other current and non-current liabilities | (11,683) | 5,952 |
| Cash flows provided by operating activities | 216,371 | 75,985 |
| Cash flows from investing activities | ||
| Payments for property, plant and equipment | (68,874) | (79,794) |
| Other, net | 129 | 2,082 |
| Cash flows used in investing activities | (68,745) | (77,712) |
| Cash flows from financing activities | ||
| Borrowings under debt agreements | 452,000 | 573,000 |
| Payments on debt and finance lease obligations | (539,332) | (545,649) |
| Repurchases of common stock | (36,145) | (37,431) |
| Proceeds from exercise of stock options | 210 | 8 |
| Payments related to tax withholding for share-based compensation | (11,038) | (12,337) |
| Cash flows used in financing activities | (134,305) | (22,409) |
| Effect of exchange rate changes on cash and cash equivalents | (85) | 2,220 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 13,236 | (21,916) |
| Cash and cash equivalents and restricted cash: | ||
| Beginning of period | 256,654 | 275,470 |
| End of period | $269,890 | $253,554 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.